Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation
These findings suggest that PFA technology may offer economic and operational advantages, including more efficient resource utilization, reduced procedural complexity and consumables use, compared to traditional ablation modalities. However, variations in hospital clinical practices may limit the generalizability of results.
Authors
- Steffen Uffenorde
- Jonatan R. Ruiz (ORCID: https://orcid.org/0000-0002-7548-7138)
- A Loma-Osorio
- Petr Neužil (ORCID: https://orcid.org/0000-0003-4334-8165)
- Ángel Martínez Brotóns
- Luisa M. Saavedra (ORCID: https://orcid.org/0000-0002-8753-5416)
- Davide Antonio Mei (ORCID: https://orcid.org/0009-0000-6345-3742)
- Giuseppe Boriani
- Petr Moučka
Institutions
- University of Modena and Reggio Emilia (IT)
- Hospital Clínico Universitario de Valencia (ES)
- Na Homolce Hospital (CZ)
- Azienda Ospedaliero-Universitaria di Modena (IT)
- Boston Scientific (Netherlands) (NL)
- Diamed Medizintechnik (Germany) (DE)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1080/13696998.2025.2575460
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78